Cepheid Market Reach Extended with Licenses in Canada and Registrations...(bacterialpopulation changing in the week...)

Date:6/3/2008

bacterial population changing in the weeks preceding delivery, nor does it help women who go into pre-term labor. Xpert GBS is uniquely positioned to yield test results in about an hour, where standard culture-based testing may take several days. The Xpert GBS test allows doctors to make a prompt treatment decision, making it an extremely useful tool in the intrapartum period preceding delivery.

Enterovirus, the cause of viral meningitis, is not a life-threatening disease and typically self-resolves in less than 10 days. However, bacterial meningitis (caused by a bacterial infection) is potentially fatal. As patients present with meningitis symptoms, the need for a test to differentiate between the two conditions is critical. Traditional tests take days to provide results, whereas the Xpert EV test can provide physicians with results in about two and a half hours. With rapid EV results, physicians are able to make better patient management and treatment decisions.

About the GeneXpert Molecular Diagnostic Platform

The GeneXpert System is a closed, self-contained, fully-integrated and automated platform that represents a paradigm shift in the automation of molecular analysis, producing accurate results in a timely manner with minimal risk of contamination. The GeneXpert System is the only system to combine on-board sample preparation with real-time PCR (polymerase chain reaction) amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed samples. Modular in design, the GeneXpert System has a variety of configurations to meet the broad range of testing demands of any clinical environment.

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq:

SOURCE Cepheid Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference